These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 172805)

  • 1. cAMP as a second messenger in central blood pressure control.
    Walland A
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 290(4):419-23. PubMed ID: 172805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further evidence for the involvement of cAMP in central blood pressure regulation.
    Walland A
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Jan; 296(2):177-81. PubMed ID: 189230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclic nucleotides and central cardiovascular control in the conscious cat.
    Clipsham PJ; Hamilton TC; Hunt AA; Poyser RH
    Eur J Pharmacol; 1980 Jul; 65(2-3):193-200. PubMed ID: 6105085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclic 3'5'-adenosine monophosphate and central circulatory control in cats and dogs.
    Delbarre B; Senon D; Schmitt H
    Clin Exp Pharmacol Physiol; 1977; 4(4):341-8. PubMed ID: 20256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular smooth muscle cell phosphodiesterase (PDE) 3 and PDE4 activities and levels are regulated by cyclic AMP in vivo.
    Tilley DG; Maurice DH
    Mol Pharmacol; 2002 Sep; 62(3):497-506. PubMed ID: 12181425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of follicle-stimulating hormone and dibutyryl adenosine 3',5'-monophosphate of a phosphodiesterase isoenzyme of the Sertoli cell.
    Conti M; Toscano MV; Petrelli L; Geremia R; Stefanini M
    Endocrinology; 1982 Apr; 110(4):1189-96. PubMed ID: 6174319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Adenosine cyclic-3',5'-monophosphate phosphodiesterase in hepatomas with different growth rates].
    Pavlova VM; Bogdanov GN; Vatolkina OE; Libinzon RE
    Eksp Onkol; 1984; 6(4):28-30. PubMed ID: 6094146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restoration of the cAMP second messenger pathway enhances cardiac preservation for transplantation in a heterotopic rat model.
    Pinsky D; Oz M; Liao H; Morris S; Brett J; Sciacca R; Karakurum M; Van Lookeren Campagne M; Platt J; Nowygrod R
    J Clin Invest; 1993 Dec; 92(6):2994-3002. PubMed ID: 8254053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dibutyryl cyclic AMP increases phosphodiesterase activity in the rat heart.
    Palmer WK; Doukas S
    Can J Physiol Pharmacol; 1984 Sep; 62(9):1225-30. PubMed ID: 6093972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclic AMP-dependent protein kinase: pivotal role in regulation of enzyme induction and growth.
    Insel PA; Bourne HR; Coffino P; Tomkins GM
    Science; 1975 Nov; 190(4217):896-8. PubMed ID: 171770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A role of cyclic nucleotides in neuromuscular transmission.
    Standaert FG; Dretchen KL; Skirboll LR; Morgenroth VH
    J Pharmacol Exp Ther; 1976 Dec; 199(3):553-64. PubMed ID: 186585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of N-2, 2'-O-dibutyryl cyclic AMP upon the interconvertible forms of cyclic AMP phosphodiesterase from human platelets.
    Pichard AL; Kaplan JC
    Biochem Biophys Res Commun; 1975 May; 64(1):342-6. PubMed ID: 167738
    [No Abstract]   [Full Text] [Related]  

  • 13. The effects of alloxanate, nicotinic acid and imidazole on secretory processes and the activities of adenylate cyclase and 3',5'-AMP phosphodiesterase in cat pancreas.
    Bonting SL; De Pont JJ; Kempen HJ; Case RM; Smith PA; Scratcherd T
    Br J Pharmacol; 1977 Oct; 61(2):243-50. PubMed ID: 200297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of cyclic AMP analogues and phosphodiesterase inhibitors on K+-induced [3H]noradrenaline release from rat brain slices and on its presynaptic alpha-adrenergic modulation.
    Wemer J; Schoffelmeer AN; Mulder AH
    J Neurochem; 1982 Aug; 39(2):349-56. PubMed ID: 6283025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of phosphodiesterase and ornithine decarboxylase by cAMP is cell cycle independent.
    Kaiser N; Bourne HR; Insel PA; Coffino P
    J Cell Physiol; 1979 Dec; 101(3):369-74. PubMed ID: 231036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central blood pressure effects of guanylyl-imido-diphosphate and cyclic guanosine-monophosphate.
    Schuhmacher P; Walland A
    Naunyn Schmiedebergs Arch Pharmacol; 1980 May; 312(1):31-5. PubMed ID: 6248798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on cyclic adenosine 3' ,5'-monophosphate levels, Adenylate cyclase and phosphodiesterase activities in the dimorphic fungus Mucor rouxii.
    Paveto C; Epstein A; Passeron S
    Arch Biochem Biophys; 1975 Aug; 169(2):449-57. PubMed ID: 170864
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of etimizol on rat brain adenyl cylase and 3',5'-adenosine monophosphate phosphodiesterase activity].
    Migas EA; Bul'on VV
    Farmakol Toksikol; 1974; 37(6):710-1. PubMed ID: 4377131
    [No Abstract]   [Full Text] [Related]  

  • 19. Activity of imidazole on the hydrolysis of cyclic AMP and cyclic GMP by bovine heart and rat liver cyclic nucleotide phosphodiesterases.
    Donnelly TE
    Arch Biochem Biophys; 1976 Mar; 173(1):375-85. PubMed ID: 4034
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of lithium on cyclic 3',5'-adenosine monophosphate formation in brain slices and its influence on phosphodiesterase.
    Krulík R
    Arzneimittelforschung; 1977; 27(9):1660-3. PubMed ID: 200249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.